Sveriges mest populära poddar
The Long Run with Luke Timmerman
Vetenskap

Ep195: Ken Song on T-cell Engagers for Autoimmune Diseases

1 tim 6 min•3 mars 2026
Ken Song, CEO of San Diego-based Candid Therapeutics, on developing bispecific T-cell engaging antibodies for autoimmune disease.

Fler avsnitt av The Long Run with Luke Timmerman

Visa alla avsnitt av The Long Run with Luke Timmerman
Ep196: Otello Stampacchia on Europe's Biotech Crisis
•1 tim 3 min
Ep194: Ansu Satpathy on Cancer and Autoimmune Drug Discovery
•1 tim 9 min
Ep193: Ron Renaud on Helping People Lose Weight With GLP-1 Medicines
•1 tim 5 min
Ep192: Kate Haviland on Following the Science to Precision Immunology
•1 tim 26 min
Ep191: Emily Conley on Small Molecules to Correct a Rare Kidney Disease
•1 tim 8 min
Ep190: Neil Kumar on Building a Rare Disease Drug Company
•1 tim 13 min
Ep189: Marc Tessier-Lavigne on Reinventing Drug Discovery with AI
•1 tim 13 min
Ep188: Art Krieg on Innate Immune System Activators for Cancer
•1 tim 9 min
Ep187: Eric Fischer on Creating a New Class of Medicines
•1 tim 6 min
Ep186: Bruce Levine & Mags McCarthy on a Song About Science and Hope
•1 tim 3 min

The Long Run with Luke Timmerman med Timmerman Report finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.